APA (7th ed.) Citation

Shunsuke Wada, Satoshi Obika, Masa-Aki Shibata, Tsuyoshi Yamamoto, Moeka Nakatani, Tetsuji Yamaoka, . . . Mariko Harada-Shiba. (2012). Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo. Elsevier.

Chicago Style (17th ed.) Citation

Shunsuke Wada, Satoshi Obika, Masa-Aki Shibata, Tsuyoshi Yamamoto, Moeka Nakatani, Tetsuji Yamaoka, Hidetaka Torigoe, and Mariko Harada-Shiba. Development of a 2',4'-BNA/LNA-based SiRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo. Elsevier, 2012.

MLA (9th ed.) Citation

Shunsuke Wada, et al. Development of a 2',4'-BNA/LNA-based SiRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo. Elsevier, 2012.